Late Outcomes of Undiagnosed Unilateral Condylar Hyperplasia and Reoccurrence of Mandibular Asymmetry.
Kamil NelkeWojciech PawlakKlaudiusz ŁuczakMaciej JaneczekEdyta PasickaJan NienartowiczGrzegorz GogolewskiMaciej DobrzyńskiPublished in: Diagnostics (Basel, Switzerland) (2024)
Unilateral condylar hyperplasia (UCH) is a rare cause of asymmetrical mandibular overgrowth because of the presence of an atypical growth in the affected condyle. SPECT (single-photon emission computed tomography) can easily establish the presence of an atypical, prolonged growth exceeding far beyond normal condylar growth and activity. A CT, CBCT, or LDCT (computed tomography, cone-beam computed tomography, or low-dose computed tomography) can confirm the diagnosis by evaluating the scope of bone overgrowth, mandibular basis/ramus asymmetry, tendency to condylar head enlargement, changes in bone density, and occurrence of differences in condylar head shapes, size, and bone structure. In most cases, a condylectomy is the procedure of choice in growing cases of UCH to remove the pathological condyle and reduce asymmetry levels. Sometimes, the growth is very slow and progressive over time, causing slowly growing asymmetry with similar symptoms to any other mandibular asymmetry, and this causes some troublesome procedures in UCH diagnostics, resulting in patients being underdiagnosed; it can even lead to some relapses in mandibular asymmetry and skeletal malocclusion after previously performed orthodontic and surgical treatment of such discrepancies. When the source of asymmetry is not identified in time, possible inadequate treatment protocols can be used. If any relapse of facial and mandibular asymmetry re-occur, SPECT and CT evaluation are necessary to evaluate if condylar hyperplasia is present and to establish what kind of surgical intervention should be used in each case.
Keyphrases
- cone beam computed tomography
- computed tomography
- image quality
- positron emission tomography
- dual energy
- low dose
- contrast enhanced
- bone mineral density
- magnetic resonance imaging
- soft tissue
- randomized controlled trial
- multiple sclerosis
- ejection fraction
- end stage renal disease
- type diabetes
- newly diagnosed
- metabolic syndrome
- pet ct
- magnetic resonance
- depressive symptoms
- minimally invasive
- skeletal muscle
- risk assessment
- bone loss
- postmenopausal women
- optical coherence tomography
- optic nerve
- patient reported outcomes
- peritoneal dialysis
- decision making